When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFE - Johnson & Johnson: Buy This Bargain Before It's Gone
Pfizer Inc.
2024-04-18 07:28:39 ET
Summary
On April 16, Johnson & Johnson released financial results for the first three months of 2024, which were within my expectations.
Tecvayli sales were $133 million in the first quarter of 2024, up 111% year over year.
Despite increased competition in the global autoimmune disease therapeutics market, the sales growth rate of most of its blockbusters has pleasantly surprised me.
As a result, I am upgrading Johnson & Johnson's rating from 'Buy' to 'Strong Buy'.